Anika Therapeutics
ANIK
About: Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.
Employees: 288
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
15% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 33
0.96% less ownership
Funds ownership: 89.41% [Q1] → 88.45% (-0.96%) [Q2]
6% less funds holding
Funds holding: 108 [Q1] → 102 (-6) [Q2]
29% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 21
30% less capital invested
Capital invested by funds: $191M [Q1] → $134M (-$56.5M) [Q2]
50% less call options, than puts
Call options by funds: $2K | Put options by funds: $4K
67% less funds holding in top 10
Funds holding in top 10: 3 [Q1] → 1 (-2) [Q2]
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
|
Barrington Research
Michael Petusky
|
$15
|
Outperform
Maintained
|
31 Jul 2025 |
Financial journalist opinion
Based on 12 articles about ANIK published over the past 30 days
